# VIALE-M (NCT04102020)

> A Study of Oral Venetoclax Tablets and Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04102020
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: AbbVie
- Conditions: Acute Myeloid Leukemia (AML)
- Interventions: Venetoclax; Azacitidine; Azacitidine
- Enrollment: 112
- Primary outcome: Number of Participants With Dose-Limiting Toxicities (DLTs) of Venetoclax in Combination With Azacitidine (AZA) (Part 1)
- Primary outcome: Number of Participants With DLTs of Venetoclax in Combination With Oral AZA (Part 3 Dose Finding Portion)

## Indexed commentary on VIALE-M so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 2 posts on X
- 1 podcast episode

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=viale-m-nct04102020